Skip to Main Content

Paper Details

Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variants.
Hum Mutat
14
2019
BRCA1, BRCA1 and, BRCA1/2, BRCA2, BRCA2 variants, breast and ovarian cancer, women
Author NameAffiliation
Melissa S ClineGenomics Institute
Yue CaoTexas A&M University, College Station
Rita CasadioUniversity of Bologna
Olivier LichtargeBaylor College of Medicine
Olivier LichtargeBaylor College of Medicine
Olivier LichtargeBaylor College of Medicine
Olivier LichtargeComputational and Integrative Biomedical Research Center, Baylor College of Medicine
Pier Luigi MartelliUniversity of Bologna
Sean D MooneyUniversity of Washington
Sean D MooneyUniversity of Washington
Kymberleigh A PagelIndiana University
Vikas PejaverUniversity of Washington
Predrag RadivojacIndiana University
Predrag RadivojacKhoury College of Computer Science, Northeastern University
Predrag RadivojacIndiana University
Predrag RadivojacKhoury College of Computer Science, Northeastern University
Castrense SavojardoUniversity of Bologna
Yang ShenTexas A&M University, College Station
Yang ShenTexas A&M University, College Station
Scott Topper
Amanda B SpurdleQIMR Berghofer Medical Research Institute
Amanda B SpurdleQIMR Berghofer Medical Research Institute
David E GoldgarHuntsman Cancer Institute, University of Utah
David E GoldgarHuntsman Cancer Institute, University of Utah
  • 1 - 24

Datasets

Release 1.2